FTV

— Fundamental Stock Analysis and Report Card

Technology : Industrial - Machinery

Located in Everett, WA, US. Fortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection. These products and services cater to diverse industries such as manufacturing, process industries, healthcare, utilities and power generation, communications, and electronics. Key brands within this segment include ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL. The company's Precision Technologies segment focuses on delivering critical measurement and control solutions. Its portfolio encompasses electrical testing and measurement instruments and related services, high-performance energetic material devices, and advanced sensor and control system solutions. These technologies are crucial for demanding sectors like power and energy management, medical equipment manufacturing, food and beverage production, aerospace and defense, off-highway vehicles, electronics, semiconductor fabrication, and various other industrial applications. This segment markets its offerings under brands such as ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX. Fortive's Advanced Healthcare Solutions division provides a comprehensive suite of hardware, software, and services specifically designed for the healthcare sector. This includes solutions for reprocessing and tracking medical instruments and devices, specialized biomedical testing tools, systems for radiation safety monitoring, and asset management services. Additionally, it offers subscription-based surgical inventory management platforms that optimize inventory and ensure regulatory adherence, alongside expert technical, analytical, and compliance services focused on determining radiation exposure. Brands in this segment include ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD. Established in 2015, Fortive Corporation maintains its corporate headquarters in Everett, Washington.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
61.83%
EBITDA Margin TTM
25.83%
Net Margin TTM
11.48%
Earnings Per Share TTM
1.76
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

Fortive Corporation
Select Period:
Q1 2026
Total ($)
Q1 2026
Margin (%)
Revenue
1.1b
-404.8m
-27.5%
Gross Income
675.5m
-205.4m
-23.3%
63%
+3.4pp
+5.7%
EBITDA
308.8m
-59.5m
-16.2%
29%
+3.9pp
+15.6%
Operating Income
191.7m
-68.9m
-26.4%
18%
+0.2pp
+1.4%
Net Income
136.4m
-35.5m
-20.7%
13%
+1.1pp
+9.4%
Earnings Per Share
0.44
-0.1
-12.0%
Operating Cash Flow
234.8m
-6.9m
-2.9%
22%
+5.6pp
+33.9%
Free Cash Flow
208.2m
-6.8m
-3.2%
19%
+4.9pp
+33.5%
Research & Development
66.5m
-38.6m
-36.7%
6%
-0.9pp
-12.8%